Abstract
Ion mobility spectrometry (IMS) gains increased pharmaceutical interest as an analytical technique for the verification of equipment cleaning. Using a fractional factorial design, we developed an IMS method for talarozole, which represents a new generation of retinoic acid metabolism blocking agents (RAMBA) that can be used for the treatment of different dermatological diseases, such as psoriasis and acne. Using a Smiths Detection Ionscan-LS and the optimal IMS settings obtained, talarozole showed a drift time of 16.648 ms, corresponding to a reduced ion mobility K 0 of 1.072 cm 2V -1s -1. Total analysis times below 1 min were achieved. Talarozole was well separated in the plasmagram from other azole compounds and the limit of detection was found to be 43 ng/ml. Swab samples collected from steel and glass plates were successfully analyzed, thereby showing that IMS is indeed a suitable technique for the quantitative analysis of talarozole in cleaning quality control. © 2011 Springer-Verlag.
Author supplied keywords
Cite
CITATION STYLE
Baert, B., Boonen, J., Thierens, C., & de Spiegeleer, B. (2011). Ion mobility spectrometry of talarozole, a new azole drug, in cleaning quality control. International Journal for Ion Mobility Spectrometry, 14(2), 109–116. https://doi.org/10.1007/s12127-011-0063-z
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.